The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback